Mitochondrial pseudomyasthenia.
暂无分享,去创建一个
[1] C. Elger,et al. Mitochondrial involvement in temporal lobe epilepsy , 2009, Experimental Neurology.
[2] C. Angelini. The role of corticosteroids in muscular dystrophy: A critical appraisal , 2007, Muscle & nerve.
[3] R. Behbehani,et al. Mitochondrial ophthalmoplegia with fatigable weakness and elevated acetylcholine receptor antibody. , 2007, Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society.
[4] P. J. Caballero,et al. Chronic Progressive External Ophthalmoplegia: A Report of 6 Cases and a Review of the Literature , 2007, The neurologist.
[5] A. Cruz-Martínez,et al. [Mitochondrial respiratory chain diseases. Evaluation and variability in 52 patients]. , 2005, Revista de neurologia.
[6] T. Klockgether,et al. Diagnostic value of mitochondrial DNA mutation analysis in juvenile unilateral ptosis , 2005, Graefe's Archive for Clinical and Experimental Ophthalmology.
[7] K. Méhes,et al. Muscle carnitine acetyltransferase and carnitine deficiency in a case of mitochondrial encephalomyopathy , 1999, Journal of Inherited Metabolic Disease.
[8] M. Gujrati,et al. Chronic asymmetric progressive external ophthalmoplegia with right facial weakness: a unique presentation of mitochondrial myopathy , 2002, Journal of neurology, neurosurgery, and psychiatry.
[9] T. Mitsui,et al. Mitochondrial damage in patients with long-term corticosteroid therapy: development of oculoskeletal symptoms similar to mitochondrial disease , 2002, Acta Neuropathologica.
[10] W. Bradley,et al. A MERRF/PEO overlap syndrome associated with the mitochondria1 DNA 3243 mutation , 1996, Neurology.
[11] J. Rossier,et al. [Atypical manifestation of progressive external ophthalmoplegia]. , 1996, Klinische Monatsblatter fur Augenheilkunde.
[12] J. Tsai,et al. CPEO and carnitine deficiency overlapping in MELAS syndrome , 1995, Acta neurologica Scandinavica.
[13] P. Peterson,et al. The treatment of mitochondrial myopathies and encephalomyopathies. , 1995, Biochimica et biophysica acta.
[14] M. Brigell,et al. Supranuclear Eye Movement Dysfunction in Mitochondrial Myopathy with tRNALEU Mutation , 1995, Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society.
[15] H. Reichmann,et al. Chronic progressive external ophthalmoplegia is associated with a novel mutation in the mitochondrial tRNA(Asn) gene. , 1994, Biochemical and biophysical research communications.
[16] R. Sakuta,et al. Point mutations in mitochondrial tRNA genes: sequence analysis of chronic progressive external ophthalmoplegia (CPEO) , 1994, Journal of the Neurological Sciences.
[17] S. Dimauro,et al. Extremely high levels of mutant mtDNAs co-localize with cytochrome c oxidase-negative ragged-red fibers in patients harboring a point mutation at nt 3243. , 1994, Human molecular genetics.
[18] C. Lee,et al. In vitro effects of glucocorticoid on mitochondrial energy metabolism. , 1991, Biochimica et biophysica acta.
[19] S. Dimauro,et al. Mitochondrial DNA deletions in progressive external ophthalmoplegia and Kearns-Sayre syndrome. , 1989, The New England journal of medicine.
[20] D B Sanders,et al. AAEE Minimonograph #25: Single‐fiber electromyography in myasthenia gravis , 1986, Muscle & nerve.
[21] A. Harding,et al. The clinical features of mitochondrial myopathy. , 1986, Brain : a journal of neurology.
[22] F. Mastaglia,et al. Mitochondrial myopathy with cardiomyopathy, lactic acidosis and response to prednisone and thiamine. , 1980, Australian and New Zealand journal of medicine.